ASRS: Premier meeting for retina science and innovation

News
Article

42nd Annual Meeting in Stockholm, the Venice of the North

Image credit: AdobeStock/JFL Photography

(Image credit: AdobeStock/JFL Photography)

The 42nd annual meeting of the American Society of Retina Specialists (ASRS) is slated to convene in the northern European capital city of Stockholm from July 17-20, 2024. The venue is the Stockholmsmässan Convention Center, Mässvägen 1, 125 80, Stockholm.

In addition to the extensive educational offerings available at the conference, attendees can enjoy the city’s beautiful architecture, numerous parks, and clean air, not to mention the extended daylight hours.

Those interested in attending can use the following link to register: https://www.asrs.org/annual-meeting/registration

Conference highlights

All times listed are expressed in Central European Time.

  • The events kick off with a Foundation Event on the evening of July 16.
  • The Opening Reception will take place on July 17 at the Grand Hotel at 7:00 pm.
  • The scientific sessions will run from July 17 to July 20 beginning at approximately 8:30 am until 5:30 pm daily
  • The Closing Reception will be on July 20 at the Vasa Museum at 8:00 pm

Scientific sessions

Educational opportunities for attendees abound over the 4 conference days, with no aspect of retina left untouched.

The planned symposia will cover multiple sessions on most of the following topics: wet and dry age-related macular degeneration, retinal detachment, diabetic retinopathy, retinal vascular disease, hereditary retinal disease and genetics, imaging, hereditary retinal disease and genetics, therapeutic complications, inflammation and infectious disease, and surgical, medical and pediatric cases.

Expert panels will be sprinkled throughout the 4 days and will address artificial intelligence, faricimab and aflibercept 8 mg in diabetic retinopathy and in wet AMD, myopic traction retinopathy, macular holes, choroidal melanoma, socioeconomics, retinopathy of prematurity, and intraocular lenses, sustainability, port delivery systems, surgical training, proliferative vitreoretinopathy, pegcetacoplan safety, and a debate on surgical training after fellowship.

In addition to the in-person sessions, the virtual meeting includes mobile app access with live stream feed and access to recording with CME Credit for 1 month after the meeting, papers on demand, films, and e-posters. Only the scientific symposia in the General Session Room will be live streamed and recorded. The mobile app (which includes the live stream and abstracts) will be distributed to both live and virtual attendees approximately 1 week before the event.

Satellite symposium

A number of satellite symposia are planned in conjunction with, but not in association with, the Annual Meeting. Those interested can check the ASRS meeting website for and locations and RSVP information.

July 17

7:15 - 8:15 am:A New Potential Option for Uveal Melanoma – The Science of Bel-Sar and Phase 3 CoMpass Trial. Location:Stockholmsmässan (Room: A2). RSVP to mbinshtok@aurabiosciences.com

July 18

11:45 AM - 1:00 pm: Changing the DME Game Plan with Faricimab – Dual Inhibition, Drying and Durability. Location:Stockholmsmässan (Room: A2)

6:00 – 9:30 pm (6:00 – 6:30 pm – dinner and exhibits; 6:30 – 9:30 pm – general session): Cole Eye Institute Imaging Summit Registration. Location: Radisson Blu Waterfront Hotel & Stockholm Waterfront Congress Centre, Nils Ericssons Plan 4, Box 604, 111 64
Stockholm, website: https://coleimagingsummit.com/

July 19

7:00 - 8:00 am: All Eyes on Geographic Atrophy. Location:
Stockholmsmässan (Room: A4)

11:50 am - 1:05 pm: Changing the nAMD Game Plan with Faricimab - Dual Inhibition, Drying and Durability. Location: Stockholmsmässan (Room: A2)

Recent Videos
WIO 2024: An educator's perspective on shattering glass ceilings in ophthalmology
Hannah Chiu, MD, FRCSC, highlights some of the early benefits of an AI-operated telephone call system for postoperative patient care at WIO 2024
Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally
ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD
© 2024 MJH Life Sciences

All rights reserved.